Internists play a vital role in identifying patients for genetic counseling for cancer risk

October 30, 2017, American College of Physicians

Patients at high risk for familial cancer, history of cancer at a young age, or history of multiple cancer occurrences may be referred to genetic counseling for genetic testing from the primary care office, which makes internists an important partner with genetic counseling.

In a commentary published in Annals of Internal Medicine, experts from the Sidney Kimmel Cancer Center at Thomas Jefferson University, Dana-Farber Cancer Institute, and Memorial Sloan Kettering Cancer Center explain three main areas in oncology where genetic evaluation is changing care for patients, and how close collaboration between internists and cancer genetic specialists is crucial.

Genetic testing in oncology has expanded rapidly in recent years to encompass testing multiple genes at a time for inherited cancer risk, evaluating tumor molecular signatures for cancer risk, and testing multiple genes in tumor specimens to inform treatment. Genetic counseling is critical for helping patients understand the implications of findings from these various genetic testing strategies and how they may affect the patient and his or her family.

Because internists are privy to a patient's total health history, including , they are in a unique position to identify patients that may benefit from genetic counseling. This is important because referral for genetic consultation and identification of an inherited gene mutation in a patient can dramatically impact cancer screening approaches and provide options for cancer prevention. Close collaboration between internists, oncologists, and cancer genetic specialists is also important in precision medicine efforts that stem from of tumors for treatment. Once a genetic mutation is identified in their patients, should discuss referral of family members for for cascade testing, or testing among other family members to determine if they carry the familial mutation.

Explore further: Genetic counseling helps determine risk for hereditary cancers

More information: Annals of Internal Medicine (2017). http://annals.org/aim/article/doi/10.7326/M17-2512

Related Stories

Genetic counseling helps determine risk for hereditary cancers

November 15, 2016
Knowing your family history is a key part in understanding your risk factors for certain diseases. While you're gathering with family this Thanksgiving, get to know more about your family's health history and how it could ...

New study for women with family history of breast, ovarian cancer

May 2, 2016
A new clinical study by Winship Cancer Institute of Emory University seeks to increase the number of women at hereditary risk for breast and ovarian cancer who are seen for genetic counseling services.

Findings suggest a gap between need, availability of genetic counseling

February 7, 2017
Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations associated with ovarian and other cancers, according to a large study by researchers at the Stanford University School ...

Mismatch between cancer genetics counseling and testing guidelines and physician practices

July 25, 2011
A new analysis has found that many doctors report that they do not appropriately offer breast and ovarian cancer counseling and testing services to their female patients. Published early online in CANCER, a peer-reviewed ...

Patient study suggests broader genetic testing for colorectal cancer risk

January 30, 2017
A new study among more than 1000 colorectal cancer patients at Dana-Farber Cancer Institute has revealed that a surprising number of patients, about 10% in total, show mutations in genes thought to increase the susceptibility ...

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

Recommended for you

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Breast cancer researcher warns against online genetic tests

June 18, 2018
We have never been so fascinated by the secrets inside our cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.